Thermo Fisher Scientific Launches CE-IVD (IVDD) Next-Generation Sequencing Test and Analysis Software to Expand Access to Precision Oncology Biomarker Testing

Oncomine Dx Express Test and Oncomine Reporter Dx informatics combine with Ion Torrent Genexus Dx System to deliver clinically relevant biomarker results in as little as one day CARLSBAD, Calif.–(BUSINESS WIRE)–Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, … [Read more…]

Poxel Announces Positive Results from Phase 2 NASH Trial (DESTINY-1) for PXL065, A Novel, Proprietary Deuterium-Stabilized R-Stereoisomer of Pioglitazone

The Phase 2 trial for the treatment of NASH met its primary efficacy endpoint; PXL065-treated patients achieved statistically significant improvements in the relative decrease in liver fat content measured by magnetic resonance imaging estimated proton density fat fraction (MRI-PDFF) at 36-weeks for all doses. Key secondary measures in PXL065-treated patients included a statistically significant improvement … [Read more…]

US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

BEIJING & SAN DIEGO–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for the initiation of a Phase 1/2 clinical study of YH001 in combination with envafolimab and doxorubicin for the treatment … [Read more…]

US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

BEIJING & SAN DIEGO–(BUSINESS WIRE)–#Biocytogen–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for the initiation of a Phase 1/2 clinical study of YH001 in combination with envafolimab and doxorubicin for the treatment … [Read more…]

Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements and Issuance of Failure-to-File Cease Trade Order

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, confirms that the Ontario Securities Commission (the “OSC”) has issued a failure to file cease trade order against the Company (“FTFCTO”) which orders that general trading, whether direct or indirect, by any person, of … [Read more…]

MultiPlan Earns Great Place to Work Certification™

94 percent of MultiPlan employees say that people of all cultures, abilities, and backgrounds are respected and valued at MultiPlan NEW YORK–(BUSINESS WIRE)–$MPLN #MPLN—MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a market-leading, technology-enabled provider of end-to-end healthcare cost management solutions, announced today its designation as a Great Place to Work-Certified™ company for 2022-2023. This distinction … [Read more…]

P3 Health Partners Expands its Footprint in Nevada

P3 Nevada Acquires Pahrump Cardiology & Family Practice PAHRUMP, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that P3 Health Partners-Nevada, LLC (“P3 Nevada”) is expanding its footprint in Nye County with the recent acquisition of a cardiology and multi-specialty practice. Pahrump Cardiology & Family … [Read more…]

Anuva Announces Series A Closure and Enters Into a Strategic Partnership With Helix

MUMBAI, India–(BUSINESS WIRE)–#asia–Anuva (formerly known as Global Gene Corp) enters into its next stage of growth focused on creating the most diverse Genomic Bio / Data Bank at scale. To enable this, Anuva is entering into a global strategic partnership with Helix, the leading population genomics and viral surveillance company in the United States. Anuva … [Read more…]

agilon health to Participate in Upcoming Investor Conferences

AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the following investor conferences: The 2022 Wells Fargo Healthcare Conference, including a fireside chat presentation on Thursday, September 8 at 10:25 AM Eastern Time. The Morgan Stanley 20th Annual Global Healthcare … [Read more…]

GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference

SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the Goldman Sachs 2022 Communacopia + Technology Conference in San Francisco, CA on Thursday, September 15, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time). A live webcast of the … [Read more…]